Peptide-targeted liposomal delivery of dexamethasone for arthritis therapy.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Peptide-targeted liposomal delivery of dexamethasone for arthritis therapy.
- Published In:
- Nanomedicine (London, England), 14(11), 1455-1469 (2019)
- Database ID:
- RPEP-04366
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-04366APA
Meka, Rakeshchandra R; Venkatesha, Shivaprasad H; Acharya, Bodhraj; Moudgil, Kamal D. (2019). Peptide-targeted liposomal delivery of dexamethasone for arthritis therapy.. Nanomedicine (London, England), 14(11), 1455-1469. https://doi.org/10.2217/nnm-2018-0501
MLA
Meka, Rakeshchandra R, et al. "Peptide-targeted liposomal delivery of dexamethasone for arthritis therapy.." Nanomedicine (London, 2019. https://doi.org/10.2217/nnm-2018-0501
RethinkPeptides
RethinkPeptides Research Database. "Peptide-targeted liposomal delivery of dexamethasone for art..." RPEP-04366. Retrieved from https://rethinkpeptides.com/research/meka-2019-peptidetargeted-liposomal-delivery-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.